Onyx Pharmaceuticals, Inc. (ONXX) Balance Sheet

Click line-items for a historical chart and %

Cash and cash equivalents	323.07M
Marketable securities, current	427.39M
Restricted cash
Receivable from collaboration partners
Prepaid expenses and other current assets	27.58M
Total current assets	1.02B
Marketable securities, non-current	5.45M
Property and equipment, net	32.33M
Intangible assets - in-process research and development	171.5M
Goodwill	193.68M
Other assets	7.03M
Total assets	1.68B
Accounts payable	2.83M
Accrued liabilities	44.33M
Accrued clinical trials and related expenses
Accrued compensation	22.49M
Lease termination exit costs, Current
Escrow account liability
Total current liabilities	122.35M
Convertible senior notes due 2016	180.7M
Liability for contingent consideration	155.12M
Deferred tax liability	51.94M
Other liabilities	25.54M
Lease termination exit costs, non-current
Commitments and contingencies	0
Common stock	73K
Additional paid-in capital	1.88B
Receivable from stock option exercises	-53K
Accumulated other comprehensive loss
Accumulated deficit	-737.91M
Total stockholders' equity	1.14B
Total liabilities and stockholders' equity	1.68B

Entities mentioned with ONXX

View All Entities